Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786149 · ClinicalTrials.gov registry record · Phase 3
Improving Varenicline Adherence and Outcomes in Homeless Smokers
A Phase 3 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 428
- Enrollment target
NCT00786149 is a Phase 3 study that has completed, run by University of Minnesota. The registered enrollment target is 428 participants.
The verdict
NCT00786149, a Phase 3 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 428 participants
- Enrollment target
Study Summary
the purpose of the study is to see if varenicline in combination with motivational counseling helps homeless cigarette smokers quit smoking.
Interventions
- OTHER Varenicline plus Motivational Interviewing counseling
- OTHER Varenicline without counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00786149
The ClinicalTrials.gov registry entry for NCT00786149 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 428 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Varenicline plus Motivational Interviewing counseling is the first listed.
NCT00786149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00786149 about?
NCT00786149 is a clinical study titled "Improving Varenicline Adherence and Outcomes in Homeless Smokers". the purpose of the study is to see if varenicline in combination with motivational counseling helps homeless cigarette smokers quit smoking.
What is the current status of trial NCT00786149?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 428 participants. The study started on 2007-09. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00786149?
The interventions under investigation include: Varenicline plus Motivational Interviewing counseling (OTHER), Varenicline without counseling (OTHER).
Who is sponsoring clinical trial NCT00786149?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.